- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Environmental Agenda
- Focus on Women's Health
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
Christopher P. Kenny (Chris)
News 16 results
Recognition
June 10, 2021
Legal 500 United States 2021 Ranks King & Spalding Practices Among the Top in the Nation
Recognition
May 20, 2021
Chambers USA 2021 Names 179 K&S Lawyers and 65 K&S Practice Groups as Leaders in Their Fields
In the News · Source: Modern Healthcare
January 27, 2021
Chris Kenny comments on the CMS denying reimbursement rate cut exemptions for hospitals' off-campus outpatient facilities
Cases & Deals
November 13, 2020
K&S Secures Precedent-Setting Victory in Challenge to Medicare DSH Program
Events 24 results
Speaking Engagement
September 29, 2021
Chris Kenny to Speak at Virginia-DC HFMA Fall Education Conference
Webinar
May 20, 2021
Practical Steps to Prepare Your Hospital’s Controlled Substances Diversion Program for Government Scrutiny
Webinar
April 29, 2021
Protecting Your CARES Act Provider Relief Funds During Audit and Enforcement: The Time to Act Is Now
Webinar
November 10, 2020
13th Annual King & Spalding Medical Device Summit
Insights 333 results
Newsletter
September 20, 2021
Health Headlines – September 20, 2021
Newsletter
September 7, 2021
Health Headlines – September 7, 2021
Newsletter
August 30, 2021
Health Headlines – August 30, 2021
Newsletter
August 23, 2021
Health Headlines – August 23, 2021